Sufentanil citrate
-
Sufentanil citrate
structure -
-
CAS No:
60561-17-3
-
Formula:
C22H30N2O2S.C6H8O7
-
Chemical Name:
Sufentanil citrate
-
Synonyms:
Propanamide,N-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenyl-,2-hydroxy-1,2,3-propanetricarboxylate (1:1);R 30730 citrate salt;Sufentanil citrate;Sufentanyl citrate;Sufenta;R 33800;Sufentanil forte;Dzuveo;Sufenta forte
- Categories:
-
CAS No:
Description
Crystalline Solid
Sufentanil citrate is an anilide.|Sufenta is a DEA Schedule II controlled substance. Substances in the DEA Schedule II have a high potential for abuse which may lead to severe psychological or physical dependence.|Sufentanil Citrate is the citrate salt form of sufentanil, a synthetic congener of fentanyl and related to the phenylpieridines, with analgesic property. Sufentanil citrate binds to and activates the mu-opioid receptor, thereby producing analgesia, respiratory depression, miosis, reduced gastrointestinal motility, and euphoria. In addition, this agent has a more rapid onset of action and shorter duration of action compared to fentanyl.|An opioid analgesic that is used as an adjunct in anesthesia, in balanced anesthesia, and as a primary anesthetic agent.
Sufentanil citrate Basic Attributes
578.67
578.23000
262-295-4
S9ZFX8403R
9740
DTXSID5048928
C47731
N01AH03
2934910000
Characteristics
193
2.90420
white to beige
96.60C
493.1ºC at 760 mmHg
9℃
H2O: soluble1mg/mL, clear
-20°C Freezer
LD50 intravenous in dog: 14100ug/kg
Safety Information
III
6.1(b)
3249
3
26/27/28-39/23/24/25-23/24/25-11
26-27-28-36/37/39-45-36/37-16-7
T+,T,F
P210-P260-P280-P301 + P310-P311
H225-H301 + H311 + H331-H370
|Danger|H300+H310+H330 (90.48%): Fatal if swallowed, in contact with skin or if inhaled [Danger Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation]|P260, P262, P264, P270, P271, P280, P284, P301+P310, P302+P350, P304+P340, P310, P320, P321, P322, P330, P361, P363, P403+P233, P405, and P501|Aggregated GHS information provided by 42 companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Management of acute moderate to severe pain.|Treatment of acute pain
Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage. (See all compounds classified as Adjuvants, Anesthesia.)|Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)|Ultrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. (From AMA Drug Evaluations Annual, 1994, p174) (See all compounds classified as Anesthetics, Intravenous.)|Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)
Citrate, Sufentanil
Sufentanil|Sufenta|9740|Schedule II - Substances in the DEA Schedule II have a high potential for abuse which may lead to severe psychological or physical dependence.|Yes
Sufentanil citrate Use and Manufacturing
Potent derivative of Fentanyl. Analgesic (narcotic). Controlled substance (opiate)
Human drugs -> Dzuveo -> EMA Drug Category|Anesthetics -> Human pharmacotherapeutic group|Human Drugs -> EU pediatric investigation plans|Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:578.7
Hydrogen Bond Donor Count:4
Hydrogen Bond Acceptor Count:11
Rotatable Bond Count:13
Exact Mass:578.22980197
Monoisotopic Mass:578.22980197
Topological Polar Surface Area:193
Heavy Atom Count:40
Complexity:687
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Latest News on Sufentanil citrate
- The world's first uniform international safety standard for plastics and rubber
- The nation's first group standard for meltblown cloth for masks is released
- Several compulsory national standards have been issued
- Japan has seized the right to formulate international standards
- Henan Efforts to Improve the Standardized Management Level of Food Production
Learn More Other Chemicals
-
Phenyltoloxamine citrate
1176-08-5
-
Citrate synthase
9027-96-7
-
Tipepidine citrate
14698-07-8
-
Toremifene citrate Formula
89778-27-8
-
SILVER CITRATE Formula
314040-92-1
-
Oxeladin citrate Formula
52432-72-1
-
CLOMIFENE CITRATE Structure
88431-47-4
-
Isopropyl citrate Structure
39413-05-3
-
What is citrate phosphate dextrose
51404-37-6
-
What is CADMIUM CITRATE
49707-39-3